Point72 Asset Management
CSTL icon

Point72 Asset Management’s Castle Biosciences CSTL Stock Holding History

Point72 Asset Management’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-119,458
Closed -$4.65M – 3895
2025
Q4 		$4.65M Sell
119,458
-217,500
-65% -$7.01M 0.01% 1906
2025
Q3 		$7.67M Buy
+336,958
New +$6.84M 0.01% 905
2025
Q2 		– Sell
-236,218
Closed -$4.73M – 2261
2025
Q1 		$4.73M Sell
236,218
-310,886
-57% -$7.7M 0.01% 948
2024
Q4 		$14.6M Buy
547,104
+47,912
+10% +$1.46M 0.03% 566
2024
Q3 		$14.2M Buy
499,192
+445,415
+828% +$11.3M 0.04% 525
2024
Q2 		$1.17M Buy
+53,777
New +$1.2M ﹤0.01% 1232
2023
Q4 		– Sell
-44,200
Closed -$747K – 2270
2023
Q3 		$747K Buy
+44,200
New +$773K ﹤0.01% 1417
2023
Q2 		– Sell
-284,847
Closed -$6.47M – 2271
2023
Q1 		$6.47M Buy
284,847
+83,466
+41% +$2.04M 0.02% 685
2022
Q4 		$4.74M Buy
+201,381
New +$4.67M 0.02% 768
2022
Q2 		– Sell
-623,291
Closed -$28M – 1436
2022
Q1 		$28M Buy
623,291
+140,439
+29% +$5.8M 0.11% 244
2021
Q4 		$20.7M Buy
482,852
+379,673
+368% +$19.8M 0.08% 330
2021
Q3 		$6.86M Buy
+103,179
New +$7.26M 0.03% 589
2021
Q1 		– Sell
-81,145
Closed -$5.45M – 998
2020
Q4 		$5.45M Buy
+81,145
New +$4.4M 0.03% 571
2020
Q3 		– Sell
-44,022
Closed -$1.66M – 954
2020
Q2 		$1.66M Buy
44,022
+16,462
+60% +$562K 0.01% 618
2020
Q1 		$822K Buy
+27,560
New +$832K 0.01% 619

Other funds holding CSTL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's CSTL Position: Q1 2026 in Review

Point72 Asset Management sold out of Castle Biosciences (CSTL) in Q1 2026, closing a stake of 119,458 shares — an estimated $4.65M sold.

Point72 Asset Management first reported a position in CSTL in Q1 2020 and held it in 15 quarters. The position peaked at $28M in Q1 2022. 186 funds tracked by Wall St. Rank hold CSTL as of Q1 2026.

  • Point72 Asset Management reported no remaining Castle Biosciences position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 119,458 Castle Biosciences shares in Q1 2026, an estimated $4.65M.
  • Point72 Asset Management first reported a position in Castle Biosciences in Q1 2020 and held it in 15 quarters.
  • Point72 Asset Management's Castle Biosciences position peaked at $28M in Q1 2022.
  • 186 funds tracked by Wall St. Rank held Castle Biosciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.